Pricing

Codiak Biosciences Inc (CDAKQ)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Douglas E. Williams
Employees:
100
35 CAMBRIDGEPARK DRIVE, SUITE 500, CAMBRIDGE, MA, 02140
617-949-4100
Codiak BioSciences focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology and neurology. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutic S.A. and Washington University.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available